Zymeworks Inc (ZYME)
14.13
-0.18
(-1.26%)
USD |
NASDAQ |
Jan 08, 16:00
13.90
-0.23
(-1.63%)
After-Hours: 20:00
Zymeworks Research and Development Expense (Annual): 143.62M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Pfizer Inc | 10.68B |
Ligand Pharmaceuticals Inc | 24.54M |
Cellectar Biosciences Inc | 27.27M |
Revance Therapeutics Inc | 79.41M |
CNS Pharmaceuticals Inc | 14.10M |